Kosuke Shimizu Selected Research

N-Methyl-D-Aspartate Receptors (NMDA Receptors)

12/2019	Suppression of Cerebral Ischemia/Reperfusion Injury by Efficient Release of Encapsulated Ifenprodil From Liposomes Under Weakly Acidic pH Conditions.
1/2014	Upregulation of N-methyl-D-aspartate receptor subunits and c-Fos expressing genes in PC12D cells by nobiletin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kosuke Shimizu Research Topics

Disease

33	Neoplasms (Cancer) 09/2022 - 06/2002
9	Carcinoma (Carcinomatosis) 09/2022 - 06/2002
9	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2004
9	Brain Ischemia (Cerebral Ischemia) 12/2019 - 05/2012
8	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2019 - 05/2012
6	Melanoma (Melanoma, Malignant) 01/2013 - 03/2008
5	Reperfusion Injury 12/2019 - 05/2012
5	Ischemia 01/2017 - 02/2009
5	Stroke (Strokes) 01/2017 - 05/2012
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2016
4	Ischemic Stroke 01/2017 - 11/2015
2	Infections 01/2023 - 08/2002
2	Cysts 01/2023 - 09/2020
2	Low Tension Glaucoma 01/2022 - 01/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2017
2	Dementia (Dementias) 01/2018 - 01/2014
2	Hypersensitivity (Allergy) 01/2017 - 05/2013
2	Sarcoma (Soft Tissue Sarcoma) 01/2012 - 11/2006
1	Cytomegalovirus Infections (Inclusion Disease) 02/2024
1	Pelvic Neoplasms 09/2022
1	Myasthenia Gravis 09/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Adenocarcinoma 01/2022
1	Urinary Retention 01/2022
1	Ocular Hypertension (Glaucoma, Suspect) 01/2022
1	Endocarditis 01/2022
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2022
1	Hemorrhage 01/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Microsatellite Instability 01/2022
1	Lymphatic Metastasis 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2021
1	Carcinogenesis 12/2020
1	Atherosclerosis 01/2019
1	Embolism (Embolus) 01/2019

Drug/Important Bio-Agent (IBA)

24	Liposomes (Liposome)IBA 10/2021 - 06/2002
8	Neuroprotective AgentsIBA 01/2017 - 05/2012
7	Peptides (Polypeptides)IBA 10/2021 - 06/2002
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 06/2002
5	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018 - 01/2011
4	pembrolizumabIBA 09/2022 - 01/2021
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 03/2019
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 08/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2008
3	nobiletinIBA 01/2018 - 01/2014
3	Small Interfering RNA (siRNA)IBA 01/2018 - 06/2012
3	Therapeutic UsesIBA 01/2016 - 02/2005
3	CholesterolIBA 01/2013 - 11/2010
3	alanyl-prolyl-arginyl-prolyl-glycineIBA 01/2011 - 09/2006
2	Pregnenolone Carbonitrile (PCN)IBA 01/2023 - 09/2020
2	omidenepag isopropylIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 12/2016
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2019 - 01/2014
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 06/2012
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2018 - 06/2012
2	MicroRNAs (MicroRNA)IBA 12/2017 - 01/2013
2	fasudil (AT 877)IBA 01/2017 - 06/2016
2	AntigensIBA 01/2017 - 05/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 08/2016
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017 - 11/2015
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2016 - 04/2013
2	Drug CarriersIBA 01/2016 - 09/2006
2	Triethylenephosphoramide (TEPA)IBA 01/2013 - 06/2012
2	Erythropoietin FDA Link 12/2012 - 05/2012
2	rhinacanthin-NIBA 01/2012 - 11/2006
2	NaphthoquinonesIBA 01/2012 - 10/2006
2	EstersIBA 01/2012 - 10/2006
2	TeaIBA 01/2011 - 01/2010
2	Oxygen (Dioxygen)IBA 02/2009 - 05/2004
2	dpp-cndacIBA 05/2008 - 06/2002
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2005 - 05/2004
1	Heparitin Sulfate (Heparan Sulfate)IBA 02/2024
1	Immune Checkpoint InhibitorsIBA 09/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2022
1	MucinsIBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	cabazitaxel FDA Link 01/2022
1	tafluprostIBA 01/2022
1	abirateroneIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	PlatinumIBA 12/2021
1	AutoantigensIBA 10/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 10/2021
1	Immunoglobulin Fab FragmentsIBA 10/2020
1	Thromboplastin (Tissue Factor)IBA 10/2020
1	solanoeclepin AIBA 09/2020
1	TriterpenesIBA 09/2020
1	ifenprodilIBA 12/2019
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019
1	EnzymesIBA 01/2019

Therapy/Procedure

17	Therapeutics 09/2022 - 06/2002
8	Drug Therapy (Chemotherapy) 01/2022 - 06/2002
3	Intravenous Injections 01/2018 - 01/2010
2	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 12/2020
2	Cystectomy 01/2021 - 01/2017
2	Thrombolytic Therapy 01/2017 - 11/2015
1	Castration 01/2022
1	Nephrectomy 01/2022
1	Transurethral Resection of Prostate (TURP) 01/2022